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So far, little is known about the physiological role of fatty acid transport protein 4 (Fatp4, Slc27a4). Mice with a
targeted disruption of the Fatp4 gene display features of a human neonatally lethal restrictive dermopathy with
a hyperproliferative hyperkeratosis, a disturbed epidermal barrier, a ﬂat dermal–epidermal junction, a reduced
number of pilo-sebaceous structures, and a compact dermis, demonstrating that Fatp4 is necessary for the for-
mation of the epidermal barrier. Because Fatp4 is widely expressed, it is unclear whether intrinsic Fatp4 deﬁciency
in the epidermis alone can cause changes in the epidermal structure or whether the abnormalities observed are
secondary to the loss of Fatp4 in other organs. To evaluate the functional role of Fatp4 in the skin, we generated a
mouse line with Fatp4 deﬁciency inducible in the epidermis. Mice with epidermal keratinocyte-specific Fatp4 de-
ﬁciency developed a hyperproliferative hyperkeratosis with a disturbed epidermal barrier. These changes resemble
the histological abnormalities in the epidermis of newborn mice with total Fatp4 deﬁciency. We conclude that Fatp4
in epidermal keratinocytes is essential for the maintenance of a normal epidermal structure.
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Recently, we generated mice with a targeted disruption of
the Fatp4 gene within intron 2 to analyze the functional sig-
nificance of Fatp4 (Herrmann et al, 2003). The Fatp4 null
mice displayed features of a human neonatally lethal restric-
tive dermopathy (Holbrook et al, 1987; Dean et al, 1993).
Their skin was characterized by a hyperproliferative hyper-
keratosis with a disturbed epidermal barrier, a flat dermal–
epidermal junction, a reduced number of pilo-sebaceous
structures, and a compact dermis. The rigid skin consistency
resulted in an altered body shape with facial dysmorphia,
generalized joint flexion contractures, and impaired move-
ment, including suckling and breathing deficiencies. The
morphological alterations were accompanied by a severely
compromised epidermal barrier function. Lipid analysis dem-
onstrated a disturbed fatty acid composition of epidermal
ceramides with a reduced proportion of very long chain fatty
acid residues within the ceramide fraction of Fatp4-deficient
epidermis. These findings revealed a previously unknown,
essential function of Fatp4 in the formation of the epidermal
barrier. Another mouse line carrying a naturally occurring
mutation in exon 3 of the Fatp4 gene leading to Fatp4 de-
ficiency (Moulson et al, 2003) displayed the same phenotype,
confirming our findings. But another genetically engineered
mouse line with a targeted disruption of the Fatp4 gene
(Gimeno et al, 2003) where exons 2 and 3 were replaced by a
selectable marker cassette exhibited a far more severe phe-
notype with early embryonic lethality before day 9.5 of ges-
tation. The reason for the differences between the two
mouse lines with disruption of the Fatp4 gene within intron 2
and exon 3, respectively, and the mouse line with disruption
of the Fatp4 gene at the 50 side of exon 2 is unclear.
Immunofluorescence microscopy localized Fatp4 to the
stratum granulosum and the stratum spinosum of the ep-
idermis (Herrmann et al, 2003). But it remained unclear
whether the lack of Fatp4 in the epidermis was the primary
cause of the dominant skin phenotype of mice with gener-
alized Fatp4 deficiency or whether the alterations in the skin
architecture were secondary phenomena because of the
lack of Fatp4 elsewhere. To answer this question, we used a
variation of Cre/lox conditional mutagenesis based on lig-
and inducible recombination (Logie and Stewart, 1995;
Metzger et al, 1995). In addition to placing loxP sites stra-
tegically within the Fatp4 gene, a Cre recombinase—mutant
estrogen receptor fusion protein (ERT2) was used to render
conditional mutagenesis of Fatp4 dependent upon the ad-
ministration of tamoxifen (Feil et al, 1997; Brocard et al,
1998; Metzger and Chambon, 2001). Because Cre-ERT2
expression was directed by the K14 promoter (Li et al,
2000), conditional mutagenesis of Fatp4 was confined to
epidermal keratinocytes after tamoxifen administration.
Thereby, we show that Fatp4 in the epidermis itself is es-
sential for the maintenance of a normal epidermal structure.
Abbreviations: AFT, after the first tamoxifen treatment; X-gal,
5-bromo-4-chloro-3-indolyl-b, D-galactopyranoside
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Results
Generation of Fatp4 mutant mice The strategy used for
the generation of Fatp4 mutant mice with epidermis-specific
Fatp4 inactivation is shown in Fig 1A. To generate mice with
a floxed Fatp4 allele (Fatp4ﬂox/wt), Fatp4neoﬂox/wt mice were
crossed with transgenic mice expressing FLPe recombinase
(Rodriguez et al, 2000). Fatp4ﬂox/wt mice were crossed with
K14-Cre-ERT2 transgenic mice (Li et al, 2000) to generate
Fatp4ﬂox/wt K14-Cre-ERT2(tg/0) double-mutant mice carrying a
floxed Fatp4 allele and the K14-Cre-ERT2 transgene. To
generate mice with an Fatp4 null allele (Fatp4neoDex3/wt),
Fatp4neoﬂox/wt mice were crossed with PGK-Cre transgenic
mice (Schwenk et al, 1995). Fatp4ﬂox/wt K14-Cre-ERT2(tg/0)
mice were crossed with Fatp4neoDex3/wt K14-Cre-ERT2(0/0) mice
to generate Fatp4neoDex3/ﬂox K14-Cre-ERT2(tg/0) mice, which
were injected with tamoxifen to generate mice with epider-
mis-specific inactivation of Fatp4, now termed esi-Fatp4.
Figure 1
Tamoxifen-induced Fatp4 null mutation in adult mouse epidermis mediated by K14-Cre-ERT2. (A) Fatp4 locus before (Fatp4wt) and after
(Fatp4neoflox) homologous recombination with the targeting vector insert. LoxP sites are depicted as open triangles, and FRT sites as open
rectangles. FLPe recombinase converts the allele Fatp4neoflox into the allele Fatp4flox, which lacks the neomycin resistance cassette. Cre re-
combinase converts the allele Fatp4flox into the null allele Fatp4Dex3, which lacks exon 3, and the allele Fatp4neoflox into the null allele Fatp4neoDex3,
which lacks exon 3 but still contains the neomycin resistance cassette. (B) PCR genotype analysis of DNA from various tissues 7 and 13 wk after the
first tamoxifen treatment (AFT). An ethidium bromide-stained agarose gel containing amplification products from K14-Cre-ERT2(0/0) Fatp4neoDex3/flox
(control) and K14-Cre-ERT2(tg/0) Fatp4neoDex3/flox (mutant, esi-Fatp4) mice, respectively, is shown. A PCR with Hfe-specific primers served as the
control reaction.
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PCR analysis was used to identify the different genotypes
and to detect the Cre-mediated recombination of the allele
Fatp4ﬂox to the allele Fatp4Dex3 (Fig 1B).
Phenotype of Fatp4 mutant mice Mice with epidermis-
specific Fatp4 deficiency (esi-Fatp4 mice) did not show any
gross abnormality in comparison with control littermates
neither 7 nor 13 wk after the first tamoxifen treatment (AFT).
Their behavior and gross appearance were also normal.
Only histological examination revealed distinct changes.
The stratum corneum of esi-Fatp4 mice was considera-
bly thicker than that of control littermates (Fig 2). The stra-
Figure2
Abnormalities generated in skin of adult
mouse by tamoxifen-induced disruption
of Fatp4mediated by K14-Cre-ERT2. Skin
of mutant mice and control littermates 7
and 13 wk after the first tamoxifen treat-
ment (AFT). Skin from the snout (A), eyelid
(B), ear (C), back (D), and foot pad (E) was
stained with hematoxylin and eosin. In
comparison with control epidermis, Fatp4
mutant (esi-Fatp4) epidermis exhibited
more cell layers in the stratum spinosum
and the basal layer. (F) Immunohistochem-
ical analysis using anti-Ki-67 antibodies
showed an increase in the number of pos-
itive cells in the basal layer and also several
positive suprabasal cells in the skin from
the eyelid of esi-Fatp4 mice compared with
control mice. Scale bar, 50 mm.
Figure 3
Differentiation of foot sole skin of Fatp4 mutant and control mice, as shown by immunofluorescence microscopy. To the right of each of the
immunofluorescence micrographs are the respective phase-contrast images of the same sections. (A) Immunostaining of Fatp4 in mouse foot sole
skin. Fatp4 is detectable only at the cell margins of the stratum granulosum subadjacent to the stratum corneum (sc) of control mice (white open
arrow). In Fatp4 mutant mice, no specific labelling can be observed (yellow open arrow). (B) Immunostaining of keratin K14 in plantar epidermis.
Whereas K14 is restricted to the stratum basale (sb) of control mice, it is also detected in the lower/middle cells of the stratum spinosum (ss) of Fatp4
mutant mice (yellow open arrow). (C) Immunostaining of K6 is seen in basal and some lower suprabasal cells in control mice (white open arrow), as
normally observed in foot sole epidermis. In the Fatp4 mutant mice, this staining includes all living layers of the foot sole (yellow bracket). (D) The
staining pattern using antisera against K10 shows all suprabasal cells (stratum spinosum and stratum granulosum; white bracket, ssþ sg) to be
positive, with considerable widening of both layers in Fatp4 mutant mice (yellow bracket, ssþ sg). (E) Keratin K2e is expressed very late during
terminal keratinocyte differentiation of the skin and is detectable only in the stratum granulosum cells of control mice (white bracket, sg), whereas in
Fatp4 mutant mice it is strongly increased in both the stratum spinosum and stratum granulosum (yellow bracket, ssþ sg). Loricrin (F), filaggrin (G),
and transglutaminase 1 (H) are typical proteins of the cornified envelope and specific components of the process of terminal keratinocyte dif-
ferentiation. They all can be detected in the upper stratum spinosum and in the stratum granulosum of control mice (F–H, white brackets). In Fatp4
mutant mice, these proteins are regularly seen in the uppermost stratum spinosum as well as most prominently in the broadened stratum granulosum
(F–H, yellow brackets). (I) The presence of claudin-1 in the cell–cell borders of all layers of the skin (white bracket, ss-sg) indicates an intact tight
junction barrier in both kinds of mice, whereas in Fatp4 mutant mice the staining is restricted to the strata spinosum and granulosum (yellow bracket,
ssþ sg). Blue staining: DAPI-stained nuclei. gl, sebaceous gland. Scale bar, 50 mm.
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tum spinosum was characterized by an increased number of
cell layers. In comparison with newborn mice with gener-
alized Fatp4 deficiency, however, the alterations were less
pronounced. The flat dermal–epidermal junction, the re-
duced number of pilo-sebaceous structures, and the con-
densed dermis with compact collagen fibers present in
newborn mice with generalized Fatp4 deficiency could not
be observed in adult esi-Fatp4 mice, neither 7 nor 13 wk
AFT. In addition, no ultrastructural differences between
control and transgenic mice could be detected, including
lamellar membranes as well as the number and shape of
lamellar bodies (data not shown).
All other organs, including the brain, intestine, liver,
spleen, kidneys, myocardium, lung, thymus, and skele-
tal muscle (not shown), examined by light microscopy ap-
peared normal in esi-Fatp4 mice both 7 and 13 wk
AFT.
Immunohistochemical analysis revealed an increased
number of Ki-67-positive nuclei in the basal layer of esi-
Fatp4 mouse epidermis in comparison with control mouse
epidermis (7 wk AFT: 45% vs 9%; 13 wk AFT: 42% vs 19%).
Whereas in control mouse skin all positive nuclei were lo-
cated in the basal layer of the epidermis or in the outer root
sheath or matrix of hair follicles (data not shown), in esi-
Fatp4 mouse skin some Ki-67-positive cells were observed
in the first suprabasal layer (Fig 2F). Thus, the observed
hyperkeratosis could be classified as a hyperproliferative
hyperkeratosis.
The immunofluorescence studies were performed on
foot sole and on snout epidermis (data not shown). For
Fatp4 immunofluorescence microscopy, we used an
antiserum that we generated against a specific peptide
(Herrmann et al, 2003). By using staining protocols without
detergent addition in any of the fixation and incubation
steps (see Materials and Methods), a decoration along the
cell margins of the stratum granulosum was seen in
Fatp4neoDex3/ﬂox K14-Cre-ERT2(0/0) mice (henceforth termed
control mice; Fig 3A, white open arrow), and a very faint but
nonspecific cytoplasmic staining (cf. Herrmann et al, 2003)
was seen in the keratinocytes of the lower stratum basale.
This specific Fatp4 staining was not detectable in tamoxi-
fen-treated Fatp4neoDex3/ﬂox K14-Cre-ERT2(tg/0) mice (esi-
Fatp4 mice; Fig 3A, yellow open arrow). Special aspects
could be observed when investigating skin appendages.
Besides the interfollicular epidermis, in control snout skin,
Fatp4 was most prominent at the cellular margins of
trichocytes of hair follicle cortex and keratinocytes of the
inner root sheath and less pronounced in those of the outer
root sheath (Fig 4A,B). Furthermore, the epithelial cells of
the sebaceous glands were also positive for Fatp4 (Fig 4C).
In mutant animals, as already mentioned, Fatp4 staining of
the interfollicular epidermis was no longer detectable and
the staining in the sebaceous glands and the outer root
sheath was also lost (Fig 4D). Remarkably, the staining of
the hair follicle cortex, the inner root sheath, and the com-
panion layer was not affected (Fig 4D, inset and E). No
specific Fatp4 staining of dermal components could be de-
tected.
As keratin K14 is expressed neither in the hair fiber nor in
the inner root sheath (Langbein et al, 1999, 2001, 2002b,
2003; for a review see Langbein and Schweizer, 2005), the
maintenance of Fatp4 staining after the tamoxifen-induced,
K14 promoter-controlled inactivation of Fatp4 in these K14-
negative tissue compartments is reasonable. Otherwise, in
the K14-positive sebaceous glands (Hughes et al, 1996) and
the outer root sheath (Coulombe et al, 1989), Fatp4 staining
was, like in the interfollicular epidermis, lost. These results
can clearly be assessed as an ‘‘internal proof’’ of the
specificity and efficiency of the knockout technique used in
this work.
The skin of esi-Fatp4 mice was hyperplastic, hyperke-
ratotic, and parakeratotic. Therefore, we investigated the
differentiation of keratinocytes, particularly the occurrence
and distribution of specific keratins and other proteins of the
cornified envelope, by using standard protocols including
detergent permeabilization (see Materials and Methods).
Keratin K14 (Fig 3B) was markedly restricted to the stratum
basale of control skin. The skin of esi-Fatp4 mice showed a
comparable immunostaining pattern but with K14 labelling
extended to the first or more suprabasal layers (Fig 3B, yel-
low open arrow), indicative of increased cell proliferation in
the Fatp4 mutant skin. This proliferative characteristic of the
esi-Fatp4 epidermis was also demonstrable by the intense
reaction for keratin K6 (Fig 3C): whereas in the foot sole
epidermis of control mice typically only the keratinocytes of
the basal layer and few suprabasal cells within the second-
ary ridges were positive for K6 (Fig 3C, white bracket), in esi-
Fatp4 mouse cells, this keratin was labelled in the basal and
also in the suprabasal layers, in the stratum spinosum, and
particularly in the stratum granulosum (Fig 3C, yellow brack-
et). Strong keratin K10 reactivity was observed in all living
suprabasal cell layers (Fig 3D, white bracket, ssþ sg), but
appeared much broader in the hyperkeratotic foot sole of
esi-Fatp4 mice (Fig 3D, yellow bracket, ssþ sg). Neither the
stratum basale nor the stratum corneum reacted in either
kind of mice. The immunostaining of keratin K2e was re-
stricted to the keratinocytes of the stratum granulosum in
control mice (Fig 3E; white bracket, sg), whereas it was
greatly widened, extending to the cells of the upper stratum
spinosum, in esi-Fatp4 mice (Fig 3E; yellow bracket, ssþ sg).
The stage of cornification of the skin keratinocytes was in-
vestigated by the immunolocalization of loricrin (Fig 3F), fi-
laggrin (Fig 3G), and transglutaminase I (Fig 3H): all of these
proteins were seen in their typical localizations in both esi-
Fatp4 and control animals, the only consistent difference
being that more cell layers showed immunoreactivity in the
skin of esi-Fatp4 mice, indicative of the hyperkeratinization
(Fig 3F–G, yellow brackets).
Immunohistochemical staining of the tight junction pro-
teins claudin-1, occludin, and protein ZO-1 virtually repro-
duced their typical wild-type localization (cf. Morita et al,
1999; Brandner et al, 2002; Langbein et al, 2002a) i.e.
occludin exclusively in the stratum granulosum (data not
shown), whereas protein ZO-1 (data not shown) and clau-
din-1 could also be detected at the cell margins of cells of
the lower strata (Fig 3I, white bracket, sb-sg; cf. also Morita
et al, 1999; Brandner et al, 2002; Langbein et al, 2002a). In
the Fatp4 mutant animals, both proteins were often detect-
ed in the additional layers of the thickened skin. Remark-
ably, under these conditions, claudin-1 was no longer
detectable in the stratum basale of esi-Fatp4 mice (Fig 3I,
yellow bracket, ssþ sg).
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Epidermal barrier function in esi-Fatp4 mice To examine
whether the observed abnormal skin structure might also be
associated with an impaired skin barrier function, two dif-
ferent techniques were applied. The substrate 5-bromo-4-
chloro-3-indolyl-b, D-galactopyranoside (X-gal) penetrated
esi-Fatp4 skin, where it was cleaved to produce a colored
precipitate by endogenous b-galactosidase activity, where-
as the skin of control mice was impermeable (Fig 4F). In
another set of experiments it was shown that the fluores-
cent dye Lucifer yellow permeated throughout the entire
epidermis in esi-Fatp4 mice; in contrast, it did not pass
through the upper layers of the stratum corneum in control
mice (Fig 4G). Thus, we concluded that the abnormal ep-
idermal structure of esi-Fatp4 mice was accompanied by a
compromised epidermal barrier function.
Discussion
Mice with generalized Fatp4 deficiency exhibit a character-
istic phenotype with distinct abnormalities in the structure
and a disturbed barrier function of the epidermis (Herrmann
et al, 2003; Moulson et al, 2003). How Fatp4 deficiency leads
to these severe alterations is still unclear. As Fatp4 acts as
an acyl-CoA synthetase for long and very long chain fatty
acids (Herrmann et al, 2001; Hall et al, 2005) and Fatp4/
mice exhibit a disturbed fatty acid composition of epidermal
ceramides (Herrmann et al, 2003), Fatp4 might play an im-
portant role in the epidermal ceramide metabolism.
The mutation within the Fatp4 gene of our mouse line and
the Fatp4-deficient mouse line described by Moulson et al
(2003) is located within intron 2 and exon 3, respectively.
Because we generated a gene trap vector to target the
Fatp4 gene with a mutant multipurpose Fatp4 allele, we had
to integrate the cassette with the selectable marker after the
first coding exon, i.e., after exon 2. Another mouse line with
a disruption of the Fatp4 gene at the 50 side of exon 2 ex-
hibits a far more severe phenotype with early embryonic
lethality before gestational day 9.5 (Gimeno et al, 2003). The
reason for this difference is still elusive. It has been spec-
ulated that the disruption of intron 2 or exon 3, respectively,
might give rise to a trunkated form of Fatp4 with a rest
activity leading to a less severe phenotype than observed
when the Fatp4 gene is disrupted within exon 1. This trun-
cated protein, however, would carry only the first 53 amino
acids of Fatp4, whereas the length of the total deduced
Fatp4 amino acid sequence is 643 amino acids.
Fatp4 is widely expressed in many organs. Its physio-
logical function in these organs has so far remained elusive.
The gene is also strongly expressed in the skin, as we have
shown at the RNA level by Northern blot analysis (Herrmann
et al, 2001) and quantitative RT-PCR (not shown), as well as
at the protein level by immunofluorescence (Herrmann et al,
2003). But proof has not been provided that the lack of
Fatp4 in the epidermis causes the phenotype of Fatp4-de-
ficient mice. It might be conceivable that the lack of Fatp4 in
another tissue or other tissues causes secondary effects on
the generation and maintenance of the epidermal structure.
To find out whether Fatp4 indeed plays a pivotal role in the
Figure4
Appendages in snout skin of Fatp4 mutant and control mice, as
shown by immunofluorescence microscopy, and disturbed epider-
mal barrier in esi-Fatp4 mice. (A–C) In control mice, Fatp4 – besides
the interfollicular epidermis – can clearly be detected in skin append-
ages, in the hair follicle, in particular, in the outer root sheath and most
prominently in the inner root sheath and in the hair cortex (cross-sec-
tion, inset in (A); longitudinal section in (B)). Note the positive large
whisker and small pelage follicles (A). The sebaceous glands are also
clearly positive for Fatp4 (C). (D–E) In mutant mice (7 wk AFT), Fatp4
staining is missed in the interfollicular skin (D, ep), the sebaceous
glands (D, gl), and the hair follicle outer root sheath (open triangles in
the inset in (D, E)). Note that the inner root sheath and the hair cortex
remain positive for Fatp4 in esi-Fatp4 mice. Remarkably, the hair follicle
companion layer also remains Fatp4 positive (triangle in E). (F) Access
of 5-bromo-4-chloro-3-indolyl-b, D-galactopyranoside (X-gal) to ear
skin. Control epidermis is impermeable to X-gal. In contrast, X-gal
permeates Fatp4 mutant skin, where it is cleaved by endogenous b-
galactosidase activity to produce a colored precipitate. (G) Diffusion of
Lucifer yellow in ear skin. The fluorescent dye Lucifer yellow does not
pass the upper layers of the stratum corneum in control mice. In con-
trast, in Fatp4 mutant mice it permeates the entire epidermis. Scale bar,
50 mm (A–E, G).
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epidermis for the maintenance of a normal skin structure,
the generation of a mouse line with keratinocyte-specific
Fatp4 deficiency (Li et al, 2000; Metzger and Chambon,
2001) appears to be a promising approach.
In this paper, we describe the generation of the first
conditional Fatp4-deficient mouse line at all. This mouse
line displays distinct changes in the structure of the epi-
dermis and a compromised epidermal barrier function re-
sembling the changes in mice with generalized Fatp4
deficiency. Thus, we show that the function of Fatp4 in ker-
atinocytes is essential for the maintenance of a normal ep-
idermal structure.
Certain features of newborn mice with generalized
Fatp4 deficiency could not be observed in our mice with
epidermis-specific Fatp4 deficiency, like the flat dermal–
epidermal junction, the reduced number of pilo-sebaceous
structures, and the condensed dermis with compact colla-
gen fibers. Whereas newborn mice with total Fatp4 deficien-
cy can be recognized at first sight because of their
characteristic appearance, esi-Fatp4 mice are not distin-
guishable from their control littermates macroscopically.
Possible explanations for the milder phenotype of adult esi-
Fatp4 mice in comparison with newborn mice with total
Fatp4 deficiency are: (1) as described (Li et al, 2000),
we treated mice at the age of 10 wk with tamoxifen for 5
consecutive days, and again for 5 consecutive days, 2, 4,
and 6 wk later, and examined them 7 and 13 wk AFT, re-
spectively. Possibly, this period of time might not be suffi-
cient for the development of all alterations observed in
newborn mice with generalized Fatp4 deficiency, and further
changes in the skin architecture might become visible after a
longer period of observation or a longer time course of ta-
moxifen treatment. (2) The recombination efficiency of K14-
Cre-ERT2 might be below 100%. A small rest activity of Fatp4
in the epidermis of esi-Fatp mice might lead to a milder
phenotype than in mice with total Fatp4 deficiency; however,
we could not detect Fatp4 protein by immunofluorescence 7
or 13 wk AFT. Furthermore, Li et al (2000) already described a
complete recombination of a floxed RXRa allele by K14-Cre-
ERT2. (3) Fatp4 might be more important for the generation
than for the maintenance of the epidermal barrier.
The epidermis of mice with generalized Fatp4 deficiency
exhibits an abnormal lipid composition, the most striking
difference being an increase of the ceramide fraction by
about 80% and a decrease of very long chain fatty acids
with at least 26 C atoms within the ceramide fraction from
64% to 26% in Fatp4-deficient mice (Herrmann et al, 2003).
Although an analysis of the lipid composition of the epider-
mis of esi-Fatp4 mice has not been performed, we assume
that the mechanisms that lead to these very similar pheno-
types are identical because of the identical underlying ge-
netic cause. Of note, in addition to their structural role in the
epidermis, ceramides are also involved in various signalling
pathways that control differentiation and proliferation
(Huwiler et al, 2000).
The availability of a mouse model with inducible epider-
mis-specific Fatp4 deficiency in the skin will enable further
projects for analysis of the details of Fatp4 function in the
skin of adult mice. By means of this mouse line, it will be
possible to determine the sequence of morphological
events that lead to the observed hyperkeratosis, to char-
acterize the metabolic changes in Fatp4-deficient epidermis
further, and to detect delayed consequences of the ob-
served morphological and functional changes.
Materials and Methods
Genotyping of Fatp4 alleles Genomic DNA was isolated from
tissues by standard techniques. The epidermis was separated from
the dermis after heating tail skin in distilled water to 641C for 10 s.
Fatp4 genotyping was performed by PCR with primer pairs specific
for the wt, the flox, the neoDex3, and the Dex3 alleles, respectively.
Generation of Fatp4 mutant mice The generation of Fatp4 mu-
tant mice has been reported previously (Herrmann et al, 2003). The
original mouse line carried the mutant allele Fatp4neoflox (Fatp4-K;
Herrmann et al, 2003) harboring a gene trap cassette in intron 2
(Fig 1A). By crossing this mouse line with a transgenic mouse line
expressing FLPe recombinase (Rodriguez et al, 2000), the gene
trap cassette was excised, and the mutant allele Fatp4neoflox was
converted into the mutant allele Fatp4flox, which carried two loxP
sites within introns 2 and 3, respectively (Fig 1A). Mice ho-
mozygous for the ‘‘floxed’’ Fatp4 allele showed no phenotypic ab-
normalities, indicating that the allele Fatp4flox was functionally fully
active. When mice carrying the Fatp4flox allele were crossed with
PGK-Cre transgenic mice (kindly provided by Klas Kullander and
Ruediger Klein) exhibiting ubiquitous Cre expression (Schwenk
et al, 1995), the Fatp4flox allele was converted into the null allele
Fatp4Dex3 (Fig 1A). Offspring homozygous for the Fatp4Dex3 or
Fatp4neoflox alleles were analyzed for morphological differences
and were found to be identical (data not shown). All procedures
were in compliance with the guidelines of the institutional animal
care and use committees, and in accordance with governmental
guidelines. Institutional approval was granted for all experiments.
To generate mice with tamoxifen-inducible Fatp4 inactivation in
the epidermis, mice carrying the Fatp4flox allele were crossed with
transgenic mice carrying the K14-Cre-ERT2 transgene that express-
es the tamoxifen-inducible Cre-ERT2 recombinase specifically in
keratinocytes (Li et al, 2000). The resulting mice used for the ex-
periments had a mixed genetic background C57BL/6–129SV/Ola.
Tamoxifen treatment As described (Li et al, 2000), tamoxifen (Sig-
ma, St. Louis, Missouri; 0.1 mg in 100 mL sunflower oil) was in-
jected intraperitoneally into female mice at the age of 10 wk for 5
consecutive days, and again for 5 consecutive days, 2, 4, and 6 wk
later. Animals were sacrificed 7 or 13 wk AFT, and tissues were
analyzed by histology, immunohistochemistry, and electron
microscopy.
Histological analysis Histological analysis of the heart, lung, liver,
spleen, kidney, stomach, duodenum, jejunum, ileum, colon, skel-
etal muscle, adipose tissue, and skin from dorsal and ventral trunk,
ears, eyelids, snout, feet, and tail from control and tamoxifen-
treated (7 wk AFT and 13 wk AFT) mice was performed as de-
scribed previously (Herrmann et al, 2003).
Antibodies The primary antibodies used in immunohistochemistry
were as follows: (1) guinea-pig antibodies against mouse Fatp4
(1:500; Herrmann et al, 2003), K14 (1:3000), K2e (1:2000) (both
from Progen Biotechnik, Heidelberg, Germany), (2) mouse anti-
bodies against transglutaminase 1 (1:20, CellSystems, St. Kathar-
inen, Germany), (3) rabbit antibodies against keratin K10 (1:500,
Covance, Denver, Pennsylvania), filaggrin (1:500, Covance), clau-
din-1 (1:100, Neomarkers Labvision, Fremont, California), loricrin
(1:500, Covance), periplakin (1:500, a gift from Dr D. Hohl, Baylor
College, Houston, Texas), and keratin K6 (1:500, Covance), (4) rat
antibodies against Ki-67 (1:200, clone TEC-3, DAKO, Glostrup,
Denmark).
The secondary antibodies used for indirect immunofluores-
cence were goat antibodies to guinea-pig, rabbit, mouse, or rat
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immunoglobulins, coupled to Alexa 568 (dilution of 1:200; Molec-
ular Probes, Eugene, Oregon).
Immunoﬂuorescence microscopy and electron microscopy In-
direct immunofluorescence microscopy procedures for mem-
brane-associated proteins and cytoskeletal components were
essentially performed as described in Herrmann et al (2003) (see
also Schmidt et al, 1997; Langbein et al, 2002a). All investigations
were performed in parallel on foot sole and snout skin of mice 7
and 13 wk AFT. In brief, the standard protocol was applied by using
cryostat sections of freshly frozen tissues, fixed in acetone (5 min
at 201C), permeabilized with 0.1% Triton X-100/PBS for 2 min,
followed by blocking with 5% normal goat serum in PBS. Primary
and secondary antibodies were applied for ca. 45 min. For Fatp4
protein demonstration, various fixative protocols were used to
prevent loss of soluble proteins (see protocols 2 and 3; Schmidt
et al, 1997). The tissues were fixed with formaldehyde and anti-
bodies applied for 45 min, or for a shorter time without using any
detergents. Negative control immunostaining reactions were per-
formed using non-immunized serum instead of the primary anti-
bodies at the respective dilution or only the secondary antibody
against immunoglobulins of the respective species. All of them
were found to be negative. Moreover, ‘‘internal controls’’ exist by
using the panel of different antibodies of several species indicated
in the paragraph ‘‘Antibodies.’’ DAPI for nuclear counterstaining
was added to the secondary antibodies. Visualization and docu-
mentation were done by using a photomicroscope (Axiophot II,
Carl Zeiss, Germany).
Electron microscopical investigations on the skin of esi-Fapt4
and control mice 7 and 13 wk AFT were conducted as described in
Herrmann et al (2003).
Skin permeability assays The diffusion of 1 mM Lucifer yellow in
Ringer’s solution (pH 7.4) at 371C was analyzed as described
(Matsuki et al, 1998). The frozen ear skin samples of animals 7 and
13 wk AFT, respectively, were sliced at a thickness of 5 mm and the
sections were analyzed by fluorescence microscopy.
In addition, barrier-dependent access of X-gal to untreated skin
was examined as described (Hardman et al, 1998).
We thank A. Peter, P. Hornsberger, G. Schmidt, S. Kaden, and S.
Praetzel for their expert technical assistance. This work was supported
by grants from the Deutsche Forschungsgemeinschaft (STR 216/11-1)
and the Dietmar-Hopp-Foundation to W. Stremmel, and the Faculty of
Medicine, University of Heidelberg to T. Herrmann.
DOI: 10.1111/j.0022-202X.2005.23972.x
Manuscript received April 26, 2005; revised July 9, 2005; accepted for
publication August 6, 2005
Address correspondence to: Wolfgang Stremmel, Department of In-
ternal Medicine IV, University of Heidelberg, Im Neuenheimer Feld 410,
69120 Heidelberg, Germany. Email: wolfgang.stremmel@email.de,
thomas_herrmann@med.uni-heidelberg.de
References
Brandner JM, Kief S, Grund C, et al: Organization and formation of the tight
junction system in human epidermis and cultured keratinocytes. Eur J
Cell Biol 81:253–263, 2002
Brocard J, Feil R, Chambon P, Metzger D: A chimeric Cre recombinase inducible
by synthetic, but not by natural ligands of the glucocorticoid receptor.
Nucleic Acids Res 26:4086–4090, 1998
Coulombe PA, Kopan R, Fuchs E: Expression of keratin K14 in the epidermis and
hair follicle: Insights into complex programs of differentiation. J Cell Biol
109:2295–2312, 1989
Dean JCS, Gray ES, Stewart KN, Brown T, Lloyd DJ, Smith NC, Pope FM: Re-
strictive dermopathy: A disorder of skin differentiation with abnormal in-
tegrin expression. Clin Genet 44:287–291, 1993
Feil R, Wagner J, Metzger D, Chambon P: Regulation of Cre recombinase activity
by mutated estrogen receptor ligand-binding domains. Biochem Biophys
Res Commun 237:752–757, 1997
Gimeno RE, Hirsch DJ, Punreddy S, et al: Targeted deletion of fatty acid transport
protein-4 results in early embryonic lethality. J Biol Chem 278:49512–
49516, 2003
Hall AM, Wiczer BM, Herrmann T, Stremmel W, Bernlohr DA: Enzymatic prop-
erties of purified murine fatty acid transport protein 4 and analysis of acyl-
CoA synthetase activities in tissues from FATP4 null mice. J Biol Chem
280:11948–11954, 2005
Hardman MJ, Paraskevi S, Banbury DN, Byrne C: Patterned acquisition of skin
barrier function during development. Development 125:1541–1552, 1998
Herrmann T, Buchkremer F, Gosch I, Hall AM, Bernlohr DA, Stremmel W: Mouse
fatty acid transport protein 4 (FATP4): Characterization of the gene and
functional assessment as a very long chain acyl-CoA synthetase. Gene
270:31–40, 2001
Herrmann T, van der Hoeven F, Gro¨ne H-J, et al: Mice with targeted disruption of
the fatty acid transport protein 4 (Fatp 4, Slc27a4) gene show features of
lethal restrictive dermopathy. J Cell Biol 161:1105–1115, 2003
Holbrook KA, Dale BA, Witt DR, Hayden MR, Toriello HV: Arrested epidermal
morphogenesis in three newborn infants with a fatal genetic disorder
(restrictive dermopathy). J Invest Dermatol 88:330–339, 1987
Hughes BR, Morris C, Cunliffe WJ, Leigh IM: Keratin expression in pilosebaceous
epithelia in truncal skin of acne patients. Br J Dermatol 134:247–256,
1996
Huwiler A, Kolter T, Pfeilschifter J, Sandhoff K: Physiology and pathophysiology
of sphingolipid metabolism and signaling. Biochim Biophys Acta
1485:63–99, 2000
Langbein L, Grund C, Kuhn C, et al: Tight junctions and compositionally related
junctional structures in mammalian stratified epithelia and cell cultures
derived therefrom. Eur J Cell Biol 81:419–435, 2002a
Langbein L, Rogers MA, Praetzel S, Aoki N, Winter H, Schweizer J: A novel
epithelial keratin, hK6irs1, is expressed differentially in all layers of the
inner root sheath, including specialized Huxley cells (‘‘Flu¨gelzellen’’) of the
human hair follicle. J Invest Dermatol 118:789–800, 2002b
Langbein L, Rogers MA, Praetzel S, Winter H, Schweizer J: K6irs1, K6irs 2, K6irs
3, and K6irs 4 represent the inner-root-sheath (IRS)-specific type II ep-
ithelial keratins of the human hair follicle. J Invest Dermatol 120:512–522,
2003
Langbein L, Rogers MA, Winter H, Praetzel S, Beckhaus U, Rackwitz HR,
Schweizer J: The catalog of human hair keratins: I. Expression of the nine
type I members in the hair follicle. J Biol Chem 274:19874–19893, 1999
Langbein L, Rogers MA, Winter H, Praetzel S, Schweizer J: The catalog of human
hair keratins: II. Expression of the six type II members in the hair follicle
and the combined catalog of human type I and type II keratins. J Biol
Chem 276:35123–35132, 2001
Langbein L, Schweizer J: The keratins of the human hair follicle. Int Rev Cytol
243:1–78, 2005
Li M, Indra AK, Warot X, et al: Skin abnormalities generated by temporally con-
trolled RXR-alpha mutations in mouse epidermis. Nature 407:633–636,
2000
Logie C, Stewart AF: Ligand-regulated site-specific recombination. Proc Natl
Acad Sci USA 92:5940–5944, 1995
Matsuki M, Yamashita F, Ishida-Yamamoto A, et al: Defective stratum corneum and
early neonatal death in mice lacking the gene for transglutaminase 1 (ker-
atinocyte transglutaminase). Proc Natl Acad Sci USA 95:1044–1049, 1998
Metzger D, Chambon P: Site- and time-specific gene targeting in the mouse.
Methods 24:71–80, 2001
Metzger D, Clifford J, Chiba H, Chambon P: Conditional site-specific recombi-
nation in mammalian cells using a ligand-dependent chimeric Cre re-
combinase. Proc Natl Acad Sci USA 92:6991–6995, 1995
Morita K, Furuse M, Fujimoto K, Tsukita S: Claudin multigene family encoding
four-transmembrane domain protein components of tight junction
strands. Proc Natl Acad Sci USA 96:511–516, 1999
Moulson CL, Martin DR, Lugus JJ, Schaffer JE, Lind AC, Miner JH: Cloning of
wrinkle-free, a previously uncharacterized mouse mutation, reveals cru-
cial roles for fatty acid transport protein 4 in skin and hair development.
Proc Natl Acad Sci USA 100:5274–5279, 2003
Rodriguez CI, Buchholz F, Galloway J, et al: High-efficiency deleted mice show
that FLPe is an alternative to Cre-loxP. Nat Genet 25:139–140, 2000
Schmidt A, Langbein L, Rode M, Praetzel S, Zimbelmann R, Franke WW: Plako-
philins 1a and 1b: Widespread nuclear proteins recruited in specific ep-
ithelial cells as desmosomal plaque components. Cell Tiss Res 29:481–
499, 1997
Schwenk F, Baron U, Rajewsky K: A cre-transgenic mouse strain for the ubiq-
uitous deletion of loxP-flanked gene segments including deletion in germ
cells. Nucleic Acids Res 23:5080–5081, 1995
FATP4 DEFICIENCY IN MOUSE EPIDERMIS 1235125 : 6 DECEMBER 2005
